182 related articles for article (PubMed ID: 24704283)
1. Vascular-homing peptides for targeted drug delivery and molecular imaging: meeting the clinical challenges.
D'Onofrio N; Caraglia M; Grimaldi A; Marfella R; Servillo L; Paolisso G; Balestrieri ML
Biochim Biophys Acta; 2014 Aug; 1846(1):1-12. PubMed ID: 24704283
[TBL] [Abstract][Full Text] [Related]
2. In vivo phage display--a discovery tool in molecular biomedicine.
Bábíčková J; Tóthová Ľ; Boor P; Celec P
Biotechnol Adv; 2013 Dec; 31(8):1247-59. PubMed ID: 23623852
[TBL] [Abstract][Full Text] [Related]
3. Identification and Characterization of Homing Peptides Using In Vivo Peptide Phage Display.
Hyvönen M; Laakkonen P
Methods Mol Biol; 2015; 1324():205-22. PubMed ID: 26202272
[TBL] [Abstract][Full Text] [Related]
4. Vascular targeting with phage peptide libraries.
Pasqualini R
Q J Nucl Med; 1999 Jun; 43(2):159-62. PubMed ID: 10429511
[TBL] [Abstract][Full Text] [Related]
5. Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery.
Li ZJ; Cho CH
J Transl Med; 2012 Sep; 10 Suppl 1(Suppl 1):S1. PubMed ID: 23046982
[TBL] [Abstract][Full Text] [Related]
6. Novel challenges in exploring peptide ligands and corresponding tissue-specific endothelial receptors.
Balestrieri ML; Napoli C
Eur J Cancer; 2007 May; 43(8):1242-50. PubMed ID: 17449238
[TBL] [Abstract][Full Text] [Related]
7. A novel vascular-targeting peptide for gastric cancer delivers low-dose TNFα to normalize the blood vessels and improve the anti-cancer efficiency of 5-fluorouracil.
Lu L; Li ZJ; Li LF; Shen J; Zhang L; Li MX; Xiao ZG; Wang JH; Cho CH
Peptides; 2017 Nov; 97():54-63. PubMed ID: 28970092
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors.
Chang DK; Chiu CY; Kuo SY; Lin WC; Lo A; Wang YP; Li PC; Wu HC
J Biol Chem; 2009 May; 284(19):12905-16. PubMed ID: 19276080
[TBL] [Abstract][Full Text] [Related]
9. Identification of homing peptides using the in vivo phage display technology.
Rivinoja A; Laakkonen P
Methods Mol Biol; 2011; 683():401-15. PubMed ID: 21053146
[TBL] [Abstract][Full Text] [Related]
10. Homing peptides as targeted delivery vehicles.
Laakkonen P; Vuorinen K
Integr Biol (Camb); 2010 Aug; 2(7-8):326-37. PubMed ID: 20657951
[TBL] [Abstract][Full Text] [Related]
11. A new phage-display tumor-homing peptide fused to antiangiogenic peptide generates a novel bioactive molecule with antimelanoma activity.
Matsuo AL; Juliano MA; Figueiredo CR; Batista WL; Tanaka AS; Travassos LR
Mol Cancer Res; 2011 Nov; 9(11):1471-8. PubMed ID: 21900362
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor vasculature with homing peptides from phage display.
Ruoslahti E
Semin Cancer Biol; 2000 Dec; 10(6):435-42. PubMed ID: 11170865
[TBL] [Abstract][Full Text] [Related]
13. Vascular-homing peptides for cancer therapy.
Lu L; Qi H; Zhu J; Sun WX; Zhang B; Tang CY; Cheng Q
Biomed Pharmacother; 2017 Aug; 92():187-195. PubMed ID: 28544932
[TBL] [Abstract][Full Text] [Related]
14. Molecular addresses of tumors: selection by in vivo phage display.
Li XB; Schluesener HJ; Xu SQ
Arch Immunol Ther Exp (Warsz); 2006; 54(3):177-81. PubMed ID: 16736105
[TBL] [Abstract][Full Text] [Related]
15. Anti-neovascular therapy using novel peptides homing to angiogenic vessels.
Oku N; Asai T; Watanabe K; Kuromi K; Nagatsuka M; Kurohane K; Kikkawa H; Ogino K; Tanaka M; Ishikawa D; Tsukada H; Momose M; Nakayama J; Taki T
Oncogene; 2002 Apr; 21(17):2662-9. PubMed ID: 11965539
[TBL] [Abstract][Full Text] [Related]
16. Peptides homing to tumor vasculature: imaging and therapeutics for cancer.
Liu Z; Wu K
Recent Pat Anticancer Drug Discov; 2008 Nov; 3(3):202-8. PubMed ID: 18991788
[TBL] [Abstract][Full Text] [Related]
17. In vivo phage display and vascular heterogeneity: implications for targeted medicine.
Trepel M; Arap W; Pasqualini R
Curr Opin Chem Biol; 2002 Jun; 6(3):399-404. PubMed ID: 12023122
[TBL] [Abstract][Full Text] [Related]
18. Potential role of vascular targeted therapy to combat against tumor.
Chen B; Jin H; Wu K
Expert Opin Drug Deliv; 2009 Jul; 6(7):719-26. PubMed ID: 19538038
[TBL] [Abstract][Full Text] [Related]
19. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
[TBL] [Abstract][Full Text] [Related]
20. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display.
Rajotte D; Arap W; Hagedorn M; Koivunen E; Pasqualini R; Ruoslahti E
J Clin Invest; 1998 Jul; 102(2):430-7. PubMed ID: 9664085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
